Menu
CCS is proud to announce its partnership with the GlassWall Syndicate to help drive investment toward the best, most effective medical research testing methods possible. The GlassWall …
Check out the conversation between CCS President and CEO, Dr. Aysha Akhtar, and Pandemic Punditry co-hosts as they discuss how animal testing is outdated and unsuccessful. …
CCS Intern, Syama Patel, and Fellow, Mikalah Singer had a virtual “sit-down” with Dr. Kristen O’Halloran Cardinal from California Polytechnic State University. Dr. O’Halloran Cardinal …
“After Animals” Podcast interviews CCS’s President and CEO, Dr. Aysha Akhtar. She explains why animal testing is unreliable, the urgency for human-specific testing, and how …
The Terasaki Institute for Biomedical Innovation, based in Los Angeles, California, is a multi-disciplinary biomedical research establishment. Focusing on technologies such as microfluidics, organ-on-a-chip, and …
Notes from The Field “Good science is not enough to persuade people to replace animal testing” – Round Table at Advances in Cell and Tissue …
MSU researchers have developed the first functioning mini human heart model—a major step in human-relevant biology models Author: Mikalah Singer, JD, CCS Fellow Researchers at …
WASHINGTON,D.C. September 21, 2020 – A new organization in the biomedical field has launched with a mission to improve lives through education, funding and championing scientific …
“Enthusiasm is the mother of effort, and without it nothing great was ever achieved.” …
The field of human-based research technologies is rapidly growing. Currently there is no one-stop source for the latest information on innovative human-specific technologies that can …
CCS is a nonprofit 501(c)(3) organization. Contributions to CCS are tax deductible to the extent permitted by law. EIN 84-3817744
